1 / 27

Hypokalemia and Hyperkalemia

Hypokalemia and Hyperkalemia. Dr Madhukar Mittal Medical Endocrinology. Hypokalemia. Spurious Extreme leukocytosis (WBC uptake of K+ in the test tube). Transcellular shift Stress induced catecholamine release Asthma, COPD exacerbation, CHF, MI/Angina, Drug withdrawal syndrome Drugs

rwade
Download Presentation

Hypokalemia and Hyperkalemia

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Hypokalemia and Hyperkalemia Dr Madhukar Mittal Medical Endocrinology

  2. Hypokalemia • Spurious • Extreme leukocytosis • (WBC uptake of K+ in the test tube)

  3. Transcellular shift • Stress induced catecholamine release • Asthma, COPD exacerbation, CHF, MI/Angina, Drug withdrawal syndrome • Drugs • Insulin • Theophylline, β2 agonists • Anabolic state • Vit B12 or Folate treatment • GM-CSF • TPN • Hypokalemic periodic paralysis • Decreased Total Body K+

  4. 3. Decreased Total Body K+ Renal Loss (urinary K+>20meq/l) Metaboic acidosis Lower GI losses Diarrhea Laxative abuse Metabolic alkalosis Villous adenoma Congenital Cl- losing diarrhea Remote vomiting Remote diuretic use Variable pH Postobstructivediuresis Drugs Aminoglycosides Cisplatin Extra-renal Loss (urinary K+<20meq/l) • Metabolic alkalosis • Mineralocorticoid excess • Primary aldosteronism • Secondary aldosteronism • ↑ mineralocorticoid (Non-aldosterone) action • Normal/↓ BP, No edema, Secondary aldosteronism • Bartter syndrome • Gitelman syndrome • Diuretic abuse • Chronic vomiting • Hypomagnesemia • Metabolic acidosis • DKA • RTA type 1 & 2 • Ureterosigmoidostomy • Amphotericin B • Acetozolamide • Normal pH • Decreased intake • GI losses

  5. Renal Loss (urinary K+>20meq/l) • Metabolic alkalosis • Mineralocorticoid excess • Primary aldosteronism • Secondary aldosteronism • ↑ mineralocorticoid (Non-aldosterone) action • Normal/↓ BP, No edema, Secondary aldosteronism • Bartter syndrome • Gitelman syndrome • Diuretic abuse • Chronic vomiting • Hypomagnesemia • Metabolic acidosis • DKA • RTA type 1 & 2 • Ureterosigmoidostomy • Amphotericin B • Acetozolamide • Normal pH • Decreased intake • GI losses

  6. Extra-renal Loss (urinary K+<20meq/l) • Metaboic acidosis • Lower GI losses • Diarrhea • Laxative abuse • Metabolic alkalosis • Villous adenoma • Congenital Cl- losing diarrhea • Remote vomiting • Remote diuretic use • Variable pH • Postobstructive diuresis • Drugs • Aminoglycosides • Cisplatin

  7. ↑Aldosterone, ↓PRA (Primary Aldosteronism) • Adrenal adenoma (Conn syndrome) • Idiopathic hyperplasia • Adrenal carcinoma • Glucocorticoid remediable aldosteronism (GRA)

  8. Hypermineralocorticolism/Aldosteronism(Metabolic alkalosis, Hypokalemia, ↑BP) • ↑↑Aldosterone, ↑PRA (Secondary Aldosteronism) • Edema states (Cirrhosis, CHF, Nephrosis) • Pregnancy (Normal physiologic response) • ↑Renin d/t ↓Renal blood flow • Renal artery stenosis • Accelerated Hypertension (renal vasoconstriction) • Malignant hypertension (arteriolar nephrosclerosis) • Primary reninism • Renin producing tumors • ↓/N BP, No edema • Bartter syndrome • Gitelman syndrome • Chronic vomiting • Diuretic abuse • Hypomagnesemia Hypertensive States

  9. Hypermineralocorticolism/Aldosteronism(Metabolic alkalosis, Hypokalemia, ↑BP) • ↓/N Aldosterone, ↓PRA (↑ Mineralocorticoid action) • Liddle syndrome • Cushing syndrome • AME (apparent mineralocorticoid excess syndrome) • Licorice/Carbenoxolone ingestion • (Glycyrrhizinic acid Ɵ 11-βHSD II enzyme) • CAH – 11βhydroxylase deficiency • DOC (deoxycorticosterone) secreting tumour

  10. Hypermineralocorticolism/Aldosteronism(Metabolic alkalosis, ↓ K+, ↓/N BP) • Bartter syndrome • Hypercalciuria • Gitelman syndrome • ↓Urinary Ca, ↓ serum Mg • Diuretic abuse • Hypomagnesemia • Chronic vomiting • Urine Cl- <10meq/l • Urine Cl- >20meq/l

  11. CVS - ECG • Flattening or inversion of T wave with ST depression • Prominent U waves • Prolonged QT (QU) interval • + prolonged PR interval, wide QRS complex • Atrial and ventricular arrhythmias • Predisposition to digitalis toxicity

  12. Clinical • NeuroMs • Weakness, flaccid paralysis • Cramps, tetany, rhabdomyolysis • Ileus, constipation, urinary retention • Endocrine • Glucose intolerance • Growth retardation, ↓ aldosterone • Renal • ↓ renal blood flow, ↓ GFR • Nephrogenic diabetes insipidus • Increased ammoniagenesis (hepatic encephalopathy) • Chloride wasting/metabolic alkalosis

  13. Treatment • Agent • KCl • Pot bicarbonate and citrate for hypokalemia associated with chronic diarrhea, RTA • Max concentration • <40 mmol/l via peripheral vein • <60 mmol/l via central vein • Infusing solution • NS • Mannitol • Rate of infusion • <20mmol/hr unless paralysis, malignant ventr arrhythmias

  14. Treatment • Montoring • Clinical – NeuroMs • ECG • Plasma K conc. • Hypokalemic periodic paralysis • Ca channel disorder • Oral KCl 0.2-0.4 mmol/Kg every 15-30 min • IV KCL in mannitol • Long term – Actazolamide 125-1000 mg/d, Triamterene 25-100 mg/d, Spironolactone 25-100 mg/d, Dichlorphenamide 50-200 mg/d

  15. Hyperkalemia • Spurious (Pseudo) • Prolonged use of tourniquet • Ischemic blood draws • RBC hemolysis in test tubes • Marked thrombocytosis or leukocytosis

  16. Transcellular shift • Metabolic acidosis • Drugs • Insulin deficiency and hypertonicity • β blockers • Tissue breakdown • Rhabdomyolysis • Tumor lysis syndrome • Intravascular hemolysis • Hyperkalemic periodic paralysis • Drug toxicity • Digitalis • succinylchloline • Chronic Hyperkalemia

  17. 3. Chronic Hyperkalemia (Metabolic acidosis, Hypokalemia) • ↓Aldosterone, ↑PRA (Hypoaldosteronism) • Primary adrenal insufficiency • Aldosteronebisynthetic defect • Mutation in aldosteronesynthase gene (cyp 11B2) • CAH – Lipoid, 3β-HSD def, 21-OH-lase deficiency • Heparin • ACE Ɵ, ARBs (selective unresposivensess to angiotensin II) • ↓Aldosterone, ↓PRA (HyporeninemicHypoaldosteronism) • NSAIDS • Chronic TIN, Diabetic Nephropathy, Mild renal failure

  18. 3. Chronic Hyperkalemia • ↓Aldosterone, ↓PRA, ↑BP, (Cl- shunt/reabsorption in distal tubule) • PHA-II (Gordon’s syndrome) • Cyclosporine • Distal Type 4 RTA • ↑Aldo, ↑PRA,↓BP (Mineralocorticoid Resistant Hyperkalemia), Impaired distal Na+ reabsorption • PHA-I • Potassium sparing diuretics - Spironolactone, Eplerenone, Triamterene, Amiloride • Trimethoprim • Pentamidine

  19. ↓Aldosterone, ↓PRA (Hypoaldosteronism) • NSAIDS • Chronic TIN • Mild renal failure • Cl- shunt/reabsorption in distal tubule (↑BP) • Cyclosporine • Type 4 RTA • Gordon syndrome (PHA-II)

  20. ↑Aldosterone, ↑PRA (Mineralocorticoid Resistant Hyperkalemia) • PHA-I • Potassium sparing diuretics • Spironolactone, Eplerenone • Triamterene, Amiloride • Trimethoprim • Pentamidine • ↓BP • Impaired distal Na+ reabsorption

  21. CVS - ECG • Tall peaked (tented) T waves (earliest change) • Short QT interval • Wide QRS, PR interval prolongs → 20 or 30 AV block • ↓ P wave amplitude → complete loss of P waves with associated junctional rhythm • QRS widens → sine wave (ventr. flutter-like) pattern • Eventual asystole

  22. Treatment • Restrict K intake to <40 mmol/day • Stop K supplements • Stop K sparing diuretics

  23. Treatment • Ca gluconate (10%) • 10 ml over 1 -3 min IV • Repeat if no change in ECG after 5-10 min • 10-20 U regular insulin + 25-50g glucose IVI • NaHCO3 3 amp (50-150mmol) in 1L of 5%D • Nebulizedβ2agonist (albuterol 20mg in 4ml NS)

  24. Treatment • Diuretics – furosemide 60-80 mg/day • Resins (sodium polysterenesulfonate) • 25-50g in 100ml of 20% sorbitol • Retention enema 50g in 50ml of 70% sorbitol in 150ml tap water • Dialysis • For patients with renal failure • Severe life-threatening hyperkalemia unresponsive to conservative treatment • Hemodialysis – most rapid and effective way • Peritoneal dialysis – only 15-20% as effective as hemodialysis

  25. Thank You

More Related